Beta-Blocker Therapy for Heart Failure: The Evidence Is In, Now the Work Begins
Article Abstract:
All patients with heart failure should take a beta blocker as long as they have no reason not to. In 2000, a study on extended-release metoprolol showed that the drug reduced mortality rates, decreased the amount of time spent in a hospital, and improved the patients' quality of life. The treatment appears to be cost effective and may even save money in the long run. Some patients may experience a brief deterioration in the quality of life shortly after beginning the drugs and many are concerned about side effects. But the long-term benefits may outweigh short-term side effects.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
The effectiveness of right heart catheterization in the initial care of critically ill patients
Article Abstract:
Cardiac catheterization using a Swan-Ganz catheter may actually be detrimental to most critically ill patients. Cardiac catheterization is often used in these patients to monitor heart function. Researchers studied the use of cardiac catheterization in 5,735 critically ill patients between 1989 and 1994. Patients who were catheterized had a slightly higher 30-day mortality rate. They also used more resources and stayed in the ICU longer. This outcome remained even when the data were adjusted for other risk factors for mortality.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Impact of the pulmonary artery catheter in critically ill patients: Meta-analysis of randomized clinical trials
Article Abstract:
A meta-analysis of thirteen published clinical trials was performed to estimate the impact of the pulmonary artery catheter (PAC) device in critically ill patients. Use of the PAC was found to neither increase overall mortality or days in hospital nor confer any benefit, indicating the lack of a clear strategy leading to improved survival with the PAC.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Lecturers set to quit for high NHS pay. The rise of the expert patient
- Abstracts: Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients
- Abstracts: Better strategies sought against obesity. Insulin effects weigh heavy on the brain. Neuroscience becomes image conscious as brain scans raise ethical issues
- Abstracts: Dentists' participation and children's use of services in the Indiana dental Medicaid program and SCHIP. Teeth with large amalgam restorations and crowns
- Abstracts: Oral health literacy among adult patients seeking dental care. The psychosocial impact of developmental dental defects in people with hereditary amelogenesis imperfecta